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Abstract
Background: Few longitudinal studies examine inflammation and lung function in asthma. We sought to determine
the cytokines that reduce airflow, and the influence of respiratory viral infections on these relationships.
Methods: Children underwent home collections of nasal lavage during scheduled surveillance periods and self-
reported respiratory illnesses. We studied 53 children for one year, analyzing 392 surveillance samples and 203
samples from 85 respiratory illnesses. Generalized estimated equations were used to evaluate associations
between nasal lavage biomarkers (7 mRNAs, 10 proteins), lung function and viral infection.
Results: As anticipated, viral infection was associated with increased cytokines and reduced FVC and FEV1.
However, we found frequent and strong interactions between biomarkers and virus on lung function. For
example, in the absence of viral infection, CXCL10 mRNA, MDA5 mRNA, CXCL10, IL-4, IL-13, CCL4, CCL5, CCL20
and CCL24 were negatively associated with FVC. In contrast, during infection, the opposite relationship was
frequently found, with IL-4, IL-13, CCL5, CCL20 and CCL24 levels associated with less severe reductions in both
FVC and FEV1.
Conclusions: In asthmatic children, airflow obstruction is driven by specific pro-inflammatory cytokines. In the
absence of viral infection, higher cytokine levels are associated with decreasing lung function. However, with
infection, there is a reversal in this relationship, with cytokine abundance associated with reduced lung function
decline. While nasal samples may not reflect lower airway responses, these data suggest that some aspects of
the inflammatory response may be protective against viral infection. This study may have ramifications for the
treatment of viral-induced asthma exacerbations.
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Background
Geographic areas with high concentrations of low-income
and minority ethnicity residents have high levels of asthma
morbidity and mortality [1–3]. The factors leading to loss
of asthma control and asthma exacerbations are complex.
Previous studies have identified atopy, inadequate treat-
ment, respiratory viral infections and environmental expo-
sures as important drivers of asthma morbidity [4–7].
The effects of real-world respiratory viral infections
on airway inflammation remain largely undefined. We
[8] and others [9–12] have examined the innate im-
mune response of children with asthma to natural
colds. We found that nasal aspirate cytokine levels
significantly increased in children with asthma. In
addition, we found that a subset of cytokines (IFN-γ,
CXCL8, CCL2, CCL4, CCL5, and CCL20) correlated
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with self-reported respiratory tract symptoms. However,
we did not examine the influences of viral infection or
nasal cytokines on airway function. Further, by limiting
comparisons to samples taken during virus-negative well
periods and viral-induced exacerbations, we ignored the
potential effects of subacute viral infection. Finally, our
cross-sectional study did not allow us to examine patterns
of variables over time, which could provide more consist-
ent information about the cytokines that drive lung func-
tion changes in chronic asthma.
The current study is drawn from an observational
cohort of asthmatic school age children from Detroit
who were concurrently enrolled in investigations exam-
ining the relationship between near-roadway exposures
on asthma outcomes [13]. In addition to collecting
measures of asthma health, we collected nasal lavage
for detection of viral infection and measurement of re-
spiratory tract cytokines and other biomarkers, and per-
formed spirometry to assess lung function. We sought
to determine the cytokines that drive reduced airflow,
together with the influence of viral infections on these
relationships. We hypothesized that children with
greater respiratory tract inflammation would demon-
strate worse airway function, and that viral infections
would increase inflammation and negatively impact
asthma symptoms and airway function. While our hy-
pothesis was generally correct, we found that, in the
presence of viral infection, higher levels of cytokines
were associated with reduced lung function decline.
Methods
Study design and screening questionnaire
This study was conducted by Community Action Against
Asthma (CAAA), a community-based participatory
research (CBPR) partnership. School-age children with
known or probable asthma were recruited using a screen-
ing questionnaire [14] distributed at community venues
and through door-to-door recruitment in neighborhoods
near highways. The questionnaire included demographic
information, eight symptom questions, and if their child
had ever been diagnosed by a medical care provider with
any of the following conditions: asthma, bronchitis, bron-
chiolitis, reactive airways disease, pneumonia, or asthmatic
bronchitis. In addition, parents were asked whether their
child had taken prescription medication for any of these
conditions in the last 12 months and, if so, whether they
were taking these medications on a daily basis. Classifica-
tion of asthma severity was based on symptom frequency
and reported inhaled steroid use (Additional file 1: Table
S1). This study was approved by the University of
Michigan Medical School Institutional Review Board
(IRBMED) (ID# HUM00018442) and conducted accord-
ing to CBPR principles under the auspices of the CAAA
Steering Committee.
Data and sample collection
Fifty-three children participated in a two-week surveil-
lance assessment period of health status each season from
fall 2010 to summer 2011. During each two-week surveil-
lance period, staff obtained spirometry, symptom reports
and nasal lavage samples during three home visits.
Respiratory symptoms were assessed using a modification
of a previously developed respiratory symptom score [15]
which assessed fever, cough, sore throat, nasal symptoms,
wheezing, difficulty breathing and interference with usual
activities (see Additional file 1: Table S2). Families were
given a calendar and a simple respiratory symptom scale
to mark the level of their symptoms.
From winter 2010 to summer 2011, measurements
were repeated during a one-week period whenever the
child experienced a symptomatic respiratory illness as
defined by a symptom score of two or higher (referred
to as a “sick period”). We intentionally set a low symp-
tom threshold in order to maximize sensitivity to detect
viral illnesses. Families contacted a central phone num-
ber when the child became ill. Staff would tally the
symptom score over the phone and when symptoms
reached the appropriate threshold, would begin a “sick
period” assessment within 48 h of the phone call (me-
dian time to first sample was 72 h after the development
of symptoms). Staff also conducted weekly telephone
calls to identify illnesses in progress that families may
not have called in to report, and would initiate a “sick
period” collection if family reported that the child had
current symptoms.
Spirometry
Using protocols that we developed and successfully
utilized in large-scale community-based asthma studies
[7], staff conducted spirometry to assess lung function
during home visits, using the EasyOne spirometer
(NDD, Andover, MA). Additional details on spiromet-
ric procedures are described in Additional file 1.
Nasal lavage
Nasal lavage samples were collected three times during a
two-week surveillance period or three times during a
one-week sick period by the field staff. Two squirts of
isotonic 0.65% sodium chloride (estimated to be < 1 ml
per nostril, B.F. Ascher, Lenexa, KS) were instilled into
the child’s nostrils Subjects then blew their nose into a
zippered plastic bag, and three ml of M4RT viral trans-
port medium (Remel, Lenexa, KS) was added. After col-
lection, samples were double bagged, placed in a
transport cooler at 0 °C, conveyed to a local laboratory
(Henry Ford Health System Epidemiology Lab) for pre-
liminary processing and freezing to − 70 °C, and subse-
quently transported to Ann Arbor on dry ice.
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Detection of respiratory viruses
Whole nasal lavage samples were homogenized using a
hand held homogenizer (Thermo Fisher Scientific, Wal-
tham, MA). Nucleic acids were extracted using TRIzol-LS
(ThermoFisher, Waltham, MA), chloroform and an RNeasy
Mini Kit (Qiagen, Valencia, CA). Samples were analyzed for
viral nucleic acid by multiplex PCR using the Seeplex
RV-15 ACE detection kit (Seegene, Concord, CA). This kit
detects human adenovirus, bocavirus 1–4, coronaviruses
229E/NL63 and OC43, enterovirus, influenza A and B,
metapneumovirus, parainfluenza viruses 1–4, RSV A and B
and rhinovirus A, B and C. For surveillance samples, all
specimens were analyzed for virus; for sick samples, speci-
mens from the same sick week were pooled prior to ana-
lysis (samples from sick periods were not pooled for
cytokine or viral copy number determination, see below).
Nasal lavage mRNA and protein expression
All nasal lavage samples were analyzed for mRNA and
protein. cDNA was synthesized from total RNA by Taq-
man reverse transcriptase kit (Qiagen). DNA was
digested with DNase I (Qiagen). CXCL8, CXCL10, IRF7,
RIG-I, MDA5, TLR3 and IFN-λ1 mRNA expression were
measured by qPCR. Specific primers and probes span-
ning exon-exon junctions (intron splice-sites) were used
to prevent amplification of genomic DNA (Additional
file 1: Table S3, Online Repository). Expression levels
were normalized to GAPDH using the ΔΔCt method.
Reactions with a cycle number higher than 35 were not
included in the analysis. CXCL8, CXCL10, CCL2, CCL4,
CCL5, CCL20, CCL24, IL-4, IL-13 and soluble ICAM-1
(sICAM) protein levels were determined by multiplex
immune assay (Affymetrix, Santa Clara, CA). Minimum
detection levels for the proteins assayed are provided in
the Additional file 1: Table S4. Biomarkers were chosen
based on previous studies showing elevations after RV
infection, our interest in examining biomarkers we had
not previously studied, difficulty of detecting some bio-
markers or cytokines in the nasal aspirate fluid, cost and
availability.
Statistical analysis
Assessment of the distribution of spirometric data and
nasal lavage biomarkers was conducted using means, me-
dians, histograms and QQ plots (data not shown). Because
of strong right skewedness, biomarker values were natural
log transformed for subsequent analyses. The effects of
viral infection on group median nasal lavage mRNA and
protein expression were analyzed by the Wilcoxon Me-
dian Test. We chose to use a non-parametric test because
the transformed cytokine distributions were still slightly
skewed, with a number of zero values and high outliers
which we did not exclude from the analysis. In addition,
because we divided subjects and samples by asthma
severity, we had a small sample size for some measures.
Finally, in the case of TLR3 and IFN-λ1 mRNAs, which
were detected in only 35 and 11% of the samples, data
were analyzed as binary variables by Fisher’s exact test.
For our primary analyses, we evaluated the strength of as-
sociation between mean respiratory tract inflammatory re-
sponses and pulmonary function using generalized
estimating equations (GEE) with an exchangeable correl-
ation structure using the identity link in the case of continu-
ous outcomes and the log link for binary ones (SAS, Cary,
NC). This design allowed us to test the influence of cytokine
on lung function with and without virus. GEE was used ra-
ther than logistic or Poisson models because of the longitu-
dinal nature of the data and the repeated observations for
each child [16, 17]. The GEE procedure can be used for
small populations [18]. All individual samples (virus-negative
and virus-positive “surveillance samples,” virus-negative and
virus-positive “sick samples”) were included in the analysis.
We adjusted for covariates including age, gender, ethnicity/
race, smoker in the home, caregiver educational attainment,
self-reported atopy, caregiver depressive symptom score,
season and whether the sample was from a surveillance or
sick period. Family income, baseline asthma severity, medi-
cation use and proximity to high-traffic highways were eval-
uated but not included in final models as they were not
significant predictors or were collinear with other covariates
in the model. In a secondary analysis, linear plots of lung
function and cytokine level when virus was either absent or
present were generated. Additional details on statistical ana-
lysis are described in Additional file 1.
Results
Study participants
Fifty-three children between 5 and 12 years-old were
enrolled. Subjects predominantly self-identified as Afri-
can-American (Table 1). The majority was reported by
their parent/caregiver to be atopic, exposed to tobacco
smoke and live in a household with an income ≤
$15,000. Most children reported symptoms or medica-
tion use consistent with mild intermittent or mild per-
sistent asthma, but one-quarter had moderate-to-severe
persistent disease. At enrollment, one-quarter of the
subjects were taking inhaled corticosteroids or used
them within the last year. Group mean FVC, FEV1 and
PEF during the first surveillance period were in the
range of normal, but FEV1/FVC ratio and FEF25–75 were
reduced (Table 2). It should be noted that, although all
children met initial criteria for participation, only 47 of
53 children performed acceptable expiratory maneuvers
for spirometric analysis.
Participant respiratory illnesses
From September 2010 to August 2011, 392 surveillance
samples were collected, 105 (26%) of which were positive
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for one or more viruses. From December 2010 to August
2011, there were 85 self-reported respiratory illnesses, for
which 233 samples were collected. Analysis of pooled
samples for each illness showed that 30 (35%) of these ill-
nesses were positive for at least one virus. RV was de-
tected in 54 out of 105 (51%) of the virus-positive
surveillance samples and 23 out of 30 (77%) of
virus-positive sick illnesses (Table 3).
Effects of viral infection on lung function
We examined the influence of asthma severity on the
lung function response to viral infection. When we di-
vided subjects into mild intermittent, mild persistent
and moderate-to-severe persistent asthma, we found
that subjects with moderate-to-severe persistent
asthma experienced significant (p < 0.05) reductions in
FVC and FEV1 after viral infection (Fig. 1). Changes in
FEV1/FVC (p = 0.08) and FEF25–75 (p = 0.09) did not
reach statistical significance.
Effects of viral infection on nasal lavage biomarkers
All nasal samples were analyzed for mRNA expression of
CXCL8, CXCL10, IFN-λ1, TLR3, MDA5, RIG-I and IRF7.
Samples were also analyzed for CXCL8, CXCL10, IL-4,
IL-13, sICAM-1, CCL2, CCL4, CCL5, CCL20 and CCL24
protein. The median individual surveillance and sick period
samples analyzed per subject was 7 (range, 1–12) and 3
(range, 2–15), respectively. MDA-5, RIG-I, IRF7, CXCL10
and CXCL8 mRNA were detected in the 73–99% of the
samples, whereas TLR3 and IFN-λ1 mRNA were detected
in 35 and 11% of the samples, respectively.
The effect of viral infection on group median cytokine
data are shown in Table 4. Viral infections were associated
with significantly increased mRNA expression of CXCL10,
RIG-I and MDA5 and protein expression of all biomarkers
tested. In addition, viral infections were associated with an
increase in the percentage of samples with detectable TLR3
and IFN-λ1 mRNA. Responses to RV and non-RV infections
were generally similar, except for TLR3 mRNA and CXCL8
protein, which were not increased in non-RV infections
(data not shown).
Next, we examined the influence of asthma severity on
the cytokine responses to viral infection. In subjects with
moderate-to-severe persistent asthma, viral infection was as-
sociated with significant increases in mRNA expression of
CXCL10 and MDA5 (Fig. 2). Viral infection was also associ-
ated with increased mRNA expression of CXCL10 in
Table 1 Participant baseline characteristics (n = 53)
Age in years, mean (SD) 9.7 (2.1)
Female gender, n (%) 23 (43.4)
Race, Non-Hispanic African-American, n (%) 46 (86.8)
Household income ≤ $15,000, n (%) 30 (56.6)
Caregiver years of education ≤12, n (%) 30 (56.6)
Caregiver depression CESD score, mean (SD) 8.8 (5.1)
Smoker in household, n (%) 36 (67.9)
Asthma severity, N (%)
Moderate or severe persistent 14 (26.4)
Mild persistent 27 (50.9)
Mild intermittent 12 (22.6)
Atopy (self-reported), yes (%) 38 (71.7)
Any asthma medication use in last 12 months, n (%)
Inhaled corticosteroids 12 (22.6)
Short acting bronchodilator only 21 (39.6)
No asthma medication 20 (37.7)
Asthma control test (ACT) score, mean (SD) 20.0 (4.2)
Table 2 Baseline surveillance valid health measures
N Median (Range)
Symptom Score 53 2.3 (0, 27)
Lung function (% of predicted) N Mean (SD)
FVC 43 98.5 (17.0)
FEV1 43 90.3 (18.3)
FEV1/FVC ratio 43 79.3 (6.6)
FEF25–75 42 70.8 (21.9)
PEF 42 91.3 (19.1)
Table 3 Participant viral infections
N % of total
Surveillance collection (N = 410)
No virus 288 70.2
Virus 94 22.9
Rhinovirus
Single infections 46 11.2
Multiple infections 4 1.0
Non-rhinovirus
Single infectionsa 39 9.5
Multiple infections 5 1.2
Cold collection (number of pooled samples = 92)
No virus 55 60.0
Virus 28 30.4
Rhinovirus
Single infections 20 21.7
Multiple infections 2 2.2
Non-rhinovirus
Single infectionsb 6 6.5
Multiple infections 0 0.0
aCoronavirus 229E/NL63 (9), RSV A (8), coronavirus OC43 (5), RSV B (4), influenza
A (4), influenza B (3), adenovirus (2), metapneumovirus (2), parainfluenza 2 (2)
bInfluenza A (2), influenza B, coronavirus 229E/NL63, parainfluenza 2, RSV B
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Fig. 1 Effect of viral infection on spirometry in subjects with moderate-to-severe persistent (black symbols), mild persistent (grey symbols) and
mild intermittent asthma (white symbols). FVC, FEV1, FEF25–75 and PEF are shown (mean ± SD). GEE models were used for pairwise comparison
of the means (*p < 0.05)
Table 4 Effect of viral infection on nasal lavage mRNA and protein expression
Virus-negative Virus-positive
mRNA N Median IQR N Median IQR p-value
CXCL8 404 4.68 (2.15, 9.71) 174 5.01 (2.45, 10.78) 0.54
CXCL10 404 0.001 (0.00, 0.01) 174 0.0098 (0.001, 0.06) < 0.01
IRF7 404 0.06 (0.02, 0.14) 174 0.06 (0.02, 0.14) 0.99
RIG-I 404 0.01 (0.00, 0.03) 174 0.02 (0.00, 0.05) 0.04
MDA5 404 0.01 (0.00, 0.03) 174 0.02 (0.01, 0.07) < 0.01
Binary N Detected (%) N Detected (%) p-value
TLR3 404 132/404 (32.7) 174 69 (39.7) 0.11
IFN-λ1 404 30/404 (7.4) 174 33 (19.0) < 0.01
Protein N Median IQR N Median IQR p-value
CXCL8 433 177.00 (71.5, 431.6) 172 253.35 (97.25, 868.9) < 0.01
CXCL10 429 397.90 (213.9, 656.2) 171 703.20 (419.5, 1553.5) < 0.01
IL-4 436 15.60 (4.9, 51.65) 175 31.10 (9.3, 75.2) < 0.01
IL-13 428 4.60 (0.0, 27.1) 167 18.80 (0.0, 37.8) < 0.01
sICAM1 431 293.20 (100.8, 643.6) 170 560.20 (207.6, 1219.2) < 0.01
CCL2 433 71.40 (26.9, 132.9) 170 103.70 (40.3, 219.6) < 0.01
CCL4 426 300.9 (40.3, 1261.9) 170 1198.65 (163.0, 3050.6) < 0.01
CCL5 433 5.00 (0.0, 18.1) 174 9.55 (0.0, 27.4) < 0.01
CCL20 439 290.3 (78.0, 651.1) 178 580.0 (186.1, 1184.5) < 0.01
CCL24 434 4.47 (1.06, 14.24) 175 9.16 (2.56, 21.06) < 0.01
Levels of mRNA expression are normalized to GAPDH. Group median data are shown except for TLR3 and IFN-λ1 mRNA, for which results were analyzed as binary
variables. Samples were divided into virus-negative and virus positive. Differences were analyzed by the Wilcoxon Median Test except for TLR3 and IFN-λ1 which
were analyzed by Fisher’s exact test
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subjects with mild persistent asthma. Viral infection was as-
sociated with an increase in the number of samples with de-
tectable TLR3 mRNA expression in subjects with mild
persistent asthma. Finally, compared to other virus-positive
groups, the number of IFN-λ1 mRNA-positive samples
tended to be higher in infected subjects with
moderate-to-severe asthma (p= 0.09).
In moderate-to-severe persistent asthmatics, viral infec-
tion was associated with increased protein abundance of
CXCL10, IL-4, sICAM-1, CCL2, CCL20 and CCL24 (Fig. 3).
In mild persistent asthmatics, viral infection was associated
with increased protein abundance of CXCL10, sICAM-1,
CCL2, CCL4, CCL5, CCL20 and CCL24. Virus-positive
samples from subjects with mild intermittent asthma
showed no significant increases in protein expression.
Associations of nasal lavage biomarker, viral infection and
lung function
Next, we evaluated the strength of association between
respiratory tract inflammatory responses and pulmonary
function using GEE, including an interaction term between
viral presence and inflammatory marker. Most unexpect-
edly, we found frequent and strong interactions between
biomarkers and virus on lung function. For FVC, statisti-
cally significant interactions between viral infection and in-
flammation were seen for CXCL10 mRNA, TLR3 mRNA,
IL-4, IL-13, CCL5, CCL20 and CCL24 (Additional file 1:
Table S5). The interaction between viral infection and
CCL4 approached statistical significance. In contrast,
CXCL10 protein showed a negative association with FVC
independently of infection.
Figure 4 shows the graphical relationships between
nasal lavage biomarker levels and FVC in the absence
and presence of viral infection. (Panels for the binary
variables TLR3 and IFN-λ mRNA are not shown.) In the
absence of virus, there were significant negative associa-
tions between biomarker and FVC for CXCL10 mRNA,
MDA5 mRNA, CXCL10, IL-4, IL-13, CCL4, CCL5,
CCL20 and CCL24. In the presence of virus, there were
significant positive associations between biomarker and
FVC for IL-4, IL-13, CCL5, CCL20 and CCL24.
Longitudinal analysis also showed a significant influence
of viral infection on the associations between biomarkers
and FEV1 (Additional file 1: Table S6). For FEV1, statisti-
cally significant interactions between viral infection and
inflammation were seen for CXCL10 and TLR3 mRNA,
IL-4 and CCL24 levels. Interactions with CCL4 and CCL5
approached statistsical significance. CXCL10 protein levels
had negative associations with FEV1, independent of viral
infection. Again, these patterns are discerned graphically
(Fig. 5). In the absence of virus, there were significant
negative associations between biomarker and FEV1 for
CXCL10, RIG-I and MDA5 mRNA. In the presence of
virus, there were significant positive associations between
biomarker and FEV1 for MDA5 mRNA, IL-4, IL-13,
sICAM-1, CCL2, CCL5, CCL20 and CCL24.
The influence of viral infection on the relationships
between nasal lavage biomarkers and FEV1/FVC, FEF25–
75 and PEF are fully described in this article’s Online Re-
pository (Additional file 1: Tables S7-S9). For these lung
function parameters there was less of an effect of viral
infection on cytokine level. For FEV1/FVC, FEF25–75 and
Fig. 2 Effect of viral infection on nasal lavage mRNAs by asthma severity. mRNA expression was measured by qPCR and normalized by GAPDH.
Medians ±IQR are shown. TLR3 and IFN-λ1 mRNA results were analyzed as binary variables (proportions and 95% confidence intervals are shown.
Pairwise comparisons of medians were performed using the Wilcoxon Rank-Sum Test (red squares, moderate-to-severe persistent asthma; blue
squares, mild persistent asthma; green squares, mild intermittent asthma; *p < 0.05, †0.05 < p < 0.10)
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PEF, statistically significant interactions between viral in-
fection and inflammation were seen for CXCL10 mRNA.
For PEF, interactions between viral infection and RIG-I
and TLR3 mRNA were also seen. RIG-I mRNA had a
negative association with FEV1/FVC independent of viral
infection. CXCL8 mRNA and protein levels had a
negative association with FEF25–75 independent of viral
infection. RIG-I and MDA5 mRNA had negative associa-
tions with PEF independent of viral infection. Finally,
viral infection was strongly associated with significant
reductions in FEF25–75.
Discussion
Previous studies have shown increased abundance of
airway cytokines following both natural [8–12, 19, 20]
and experimental [21, 22] colds. In this report, we
examine the interactive effects of viral infection and
airway cytokines on lung function in patients with
Fig. 3 Effects of viral infection on nasal lavage cytokine concentrations by asthma severity (median ± IQR). Cytokines were measured by multiplex
immune assay. Pairwise comparisons of medians were performed using the Wilcoxon Rank-Sum Test (black symbols, moderate-to-severe
persistent asthma; grey symbols, mild persistent asthma; white symbols, mild intermittent asthma; *p < 0.05)
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Fig. 4 Effect of viral infection on the relationships between log-transformed nasal lavage biomarker levels and percent predicted FVC. In the
absence of virus, we found negative associations between biomarker level and FVC (unadjusted 95% confidence intervals are shown in light grey,
solid lines indicate a statistically significant association between cytokine and FVC by GEE; dashed lines indicate no statistically significant
association). However, in the presence of virus, increasing levels of biomarker had a positive effect on FVC (unadjusted 95% confidence intervals
are shown in dark grey; solid lines indicate a statistically significant association). For clarity individual data points are not shown here, but may be
found in Additional file 2: Figure S1
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Fig. 5 Effect of viral infection on the relationships between log-transformed nasal lavage biomarker levels and percent predicted FEV1. In the
absence of virus, we found negative associations between biomarker level and FEV1 (95% confidence intervals are shown in light grey, with solid
lines indicating a significant association between cytokine and FEV1 by GEE; dashed lines indicate no statistically significant association). In the
presence of virus, increasing levels of biomarker had a positive effect on FEV1 (95% confidence intervals are shown in dark grey; solid lines indicate a
statistically significant association). For clarity individual data points are not shown here, but may be found in Additional file 3: Figure S2
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asthma. We anticipated that, in the absence of virus,
children with greater airway inflammation would dem-
onstrate worse airway function. Consistent with this, in
the absence of viral infection, several nasal lavage bio-
markers correlated negatively with lung function. For ex-
ample, CXCL10 mRNA, MDA5 mRNA, CXCL10, IL-4,
IL-13, CCL4, CCL5, CCL20 and CCL24 were each nega-
tively associated with FVC. We also expected that viral in-
fections would increase inflammation and negatively
impact airway function. Accordingly, we found that viral
infection had independent positive associations with
nearly all nasal lavage biomarkers and, in subjects with
moderate-to-severe persistent asthma, negative influences
on FVC and FEV1. However, we found many cases in
which there was a significant interactive effect between
viral infection and lung function, in that the simultaneous
presence of viral infection and high cytokine levels was as-
sociated with less severe reductions in lung function.
Among other associations, in the presence of a virus, IL-4,
IL-13, CCL5, CCL20 and CCL24 each positively correlated
with both FVC and FEV1. Thus, whereas airway in-
flammation is associated with reduced lung function
in the absence of viral infection, cytokine expression
is associated with a diminution of lung function defi-
cits caused by viral infection.
Cytokines promote proliferation and chemotaxis of
phagocytes and granulocytes expressing antiviral sub-
stances including granule proteins, antimicrobial peptides,
proteolytic enzymes and reactive oxygen species, consist-
ent with a protective function. On the other hand, an ex-
uberant response to RV, a virus that infects relatively few
airway cells [23, 24] and possesses minimal cytotoxic ef-
fects compared to influenza or adenovirus [25], could be
maladaptive. In a mouse model of RV infection, CXCR2
[26] and TLR2 [27] null mice both show reduced airway
inflammation and responsiveness but no change in viral
load, suggesting that cytokines mediate RV-induced tissue
injury. However, in the present study, we show that, in the
context of respiratory viral infection, higher expression of
pro-inflammatory cytokines is associated with less severe
reductions in lung function. This study may have ramifica-
tions for the treatment of viral-induced asthma exacerba-
tions. For example, treatments aimed at reducing the
expression of specific pro-inflammatory cytokines may re-
duce symptoms but also attenuate the potential protective
effects of these cytokines on lung function. Indeed, a re-
cent multicenter study of children admitted to the emer-
gency department for asthma exacerabtions showed that
viral detection was associated with failure of management
with oral corticosteroids and inhaled bronchodilators [28].
As noted above, we also obtained important informa-
tion regarding the influence of airway cytokines on lung
function in the absence of viral infection. IL-4, IL-13 and
other type 2 cytokines have long been known to be
drivers of allergic asthma [29, 30], and many studies have
shown increased chemokine levels in the airways of pa-
tients with asthma compared to controls [31–39]. In our
longitudinal study, we found that, in the absence of viral
infection, CXCL10, IL-4, IL-13, CCL4, CCL5, CCL20 and
CCL24 were each negatively associated with FVC. We
also found that CXCL10 mRNA MDA5 mRNA and
IFN-λ1 mRNA were each negatively associated with FVC
and FEV1. mRNA expression of CXCL10 and MDA5 are
each known to be induced by IFN-γ, a type 1 cytokine
[40, 41]. While we did not measure IFN-γ, these data sug-
gest a potential negative influence of this cytokine on lung
function in urban children with chronic asthma in the
uninfected state. Levels of bronchoalveolar IFN-γ, a ca-
nonical type 1 cytokine, were recently associated with se-
vere asthma [42]. Exhaled breath IFN-γ was noted to be a
significant indicator of childhood asthma severity, as
measured by FEV1 [43].
We were initially surprised that airway cytokines cor-
related with FVC more strongly than pulmonary function
parameters. However, FVC has previously been noted to
negatively correlate with outdoor and indoor environmen-
tal exposures in children [44–47] and adults [48]. FVC in
children has also been negatively correlated with various
biomarkers including airway macrophage carbon content
[45], exhaled breath malondialdehyde [46] and sputum
dipalmitoylphosphatidylcholine [49].
We also obtained new information on the influence of
asthma severity on the response to viral infection.
Virus-induced induction of airway cytokines was not de-
creased in children with moderate-to-severe persistent
asthma compared to subjects less severe disease, and in
many cases viral-induced increases in cytokine level were
significant in subjects with persistent asthma but not sub-
jects with intermittent asthma. While there were signifi-
cant overlapping ranges between the asthma severity
groups, these data, obtained from asthmatic subjects
experiencing natural colds, do not support the concept
that patients with severe asthma have deficient antiviral
responses [50–52]. On the other hand, our data are
consistent with a recent study showing that, following ex-
perimental RV infection, subjects with allergic asthma
show greater levels of nasal and bronchial cytokines,
chemokines and IFNs compared to control subjects [53].
In addition, the absence of a reduction in viral-induced
mRNA or protein expression in children with moderate-
to-severe persistent asthma demonstrates that the positive
associations we found between nasal lavage cytokine level
and lung function are not due to increased cytokine pro-
duction in subjects with better lung function.
There are several limitations to our study. First, we used
nasal lavage to sample the respiratory tract of childrenwith
asthma. This method allowed repeated collection of sam-
ples from children as young as 5 years-old in a relatively
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non-invasive manner. While previous studies have shown
that gene expression among asthmatic children is altered
similarly in nasal and bronchial airways [53, 54], measure-
ments of nasal lavage cannot actually represent the airway
biology, and we did not validate our method by comparing
our results with lower respiratory tract specimens such as
sputum, breath condensate or bronchoalveolar lavage.
Second, we studied a relatively small number of children
(n = 53). Third, we found that 26.1% of surveillance sam-
ples were positive for virus, compared to 33.7% of
self-reported respiratory illnesses. Thus, subjects were
only slightly more likely to have a virus during
self-reported sick periods than during surveillance sample
collection. We believe the low viral detection rate during
symptomatic episodes can be explained by the fact that
samples from symptomatic illnesses were not collected in
the fall and instead were only collected from January to
August, when rhinovirus infections are less prevalent.
Cold-like illnesses were unlikely to represent
false-negative viral infections, as they were unaccompan-
ied by increases in nasal aspirate MDA5, a double-
stranded RNA pattern recognition receptor which was
increased in virus-positive samples and has been shown to
be induced following RV infection [55]. Nor were
cold-like illnesses associated with reduced pulmonary
function. Also, the symptom threshold for “sick” sample
collection was quite low (2 or more). The reasoning be-
hind this was to increase the likelihood of capturing viral
illnesses for study. We also offered a $50 financial reim-
bursement for each sick period assessment which served
to offset the family time and effort needed to participate
in sick assessment/nasal secretion collection. These design
elements contributed to a low viral detection rate. For ex-
ample, a symptom score of two could be achieved simply
with a runny and stuffy nose, which could easily represent
allergic rhinitis rather than a cold. Fourth, despite exten-
sive training and coaching in spirometry, many expiratory
maneuvers were excluded due to inadequate data quality.
We have evaluated the impact of our data cleaning proce-
dures and found no systematic exclusion of children com-
pared to the overall study population, and thus feel these
procedures are unlikely to introduce selection bias. Fifth,
the current analysis evaluates associations between bio-
marker levels, viral detection, and spirometry obtained on
the same day, and does not evaluate for the possibility of
lagged effects. Sixth, some of our assessments, such as
medication use, asthma severity, and atopy, were based on
self-report and were not independently validated, leaving
open the possibility of measurement error. Seventh, our
data from urban children with asthma may not be
generalizable to other groups of asthmatic children. As we
have shown previously [14], these children tend to be
undertreated, as reflected by the number of subjects who
were not taking medication (and therefore labeled as
“intermittent asthmatics”). Urban children with asthma
who are not treated with inhaled steroids may be more
susceptible to viral-induced reductions in airway function
than suburban children [56, 57]. Eighth, we did not take
into account bacterial colonization in our study. Bacterial
colonization could alter the response to rhinovirus infec-
tion [58].
Finally, while we found that proximity to high-traffic
highways was not a significant predictor of lung function
or the relationship between viral exposure and lung func-
tion, we have not yet formally examined the effect of spe-
cific exposures. Detroit has a history of elevated air
pollution and nonattainment of the ozone and particulate
matter standards [59]. We previously examined relation-
ships between lung function and ambient levels of ozone
and particulate matter in a longitudinal cohort study of
school-age children with asthma in Detroit [7]. In a
two-pollutant model including PM10 and O3, there was an
association between O3 exposure and diurnal variation of
FEV1 1 day after exposure in children without self-re-
ported cold symptoms and a larger odds ratio for children
with cold symptoms. It is therefore conceivable that spe-
cific pollutants could have intensified the effects of viral
infection on lung function.
Conclusions
We conclude that in urban children with asthma, in the
absence of respiratory virus, selected nasal lavage cyto-
kines are significantly associated with reduced lung
function. These data firmly establish the link between
airway inflammation and asthma severity in a longitu-
dinal cohort of children with stable asthma. However,
in the presence of viral infection, there is a reversal in
the relationship between nasal cytokines and clinical
outcome, with higher levels correlating with less severe
reductions in lung function. While nasal samples may
not reflect lower airway responses, these data suggest
that some aspects of the inflammatory response may be
protective against viral infection. This study provides
new insight into the host response to respiratory viral
infections, and may have ramifications for the treat-
ment of viral-induced asthma exacerbations.
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